Discovery of thieno[2,3- d ]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model
RSC Advances · 2026 · 16 (23) · 21079-21098
DOI: 10.1039/d5ra09370h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Hamed W El-Shafey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University Mansoura 35516 Egypt abdelrahmanhamdi2012@mans.edu.eg. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Breast cancer continues to be the most common malignancy in women and a major contributor of cancer-related mortality, emphasizing the need for novel therapeutic agents.
Autor:innen und Institutionen
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University Mansoura 35516 Egypt abdelrahmanhamdi2012@mans.edu.eg.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University Cairo 11823 Egypt.
- Department of Pharmacology, College of Pharmacy, The Islamic University Najaf 54001 Iraq.
- Department of Histology and Cell Biology, Faculty of Medicine, Sohag University Sohag 82524 Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University Mansoura 35516 Egypt.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P. O. Box 2457 Riyadh 11451 Saudi Arabia.
ORCID-Profile: Hamed W El-Shafey, Abdelrahman Hamdi, Mohamed R Elnagar, Sahar M Gebril, Abdullah Haikal, Adel S El-Azab, Simone Brogi, Ibrahim A Al-Suwaidan, Alaa A-M Abdel-Aziz
Förderung
- King Saud University
Zitieren
APA
El-Shafey, H. W., Hamdi, A., Elnagar, M. R., Gebril, S. M., Haikal, A., El-Azab, A. S., Brogi, S., Al-Suwaidan, I. A., & Abdel-Aziz, A. A. (2026). Discovery of thieno[2,3- d ]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model. RSC Advances, 16(23), 21079-21098. https://doi.org/10.1039/d5ra09370h
Vancouver
El-Shafey HW, Hamdi A, Elnagar MR, Gebril SM, Haikal A, El-Azab AS, et al. Discovery of thieno[2,3- d ]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model. RSC Advances. 2026;16(23):21079-21098. doi:10.1039/d5ra09370h
BibTeX
@article{ElShafey2026,
author = {El-Shafey, Hamed W and Hamdi, Abdelrahman and Elnagar, Mohamed R and Gebril, Sahar M and Haikal, Abdullah and El-Azab, Adel S and Brogi, Simone and Al-Suwaidan, Ibrahim A and Abdel-Aziz, Alaa A-M},
title = {Discovery of thieno[2,3- d ]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {23},
pages = {21079--21098},
doi = {10.1039/d5ra09370h}
}
EUVIMED